Effects of glucocorticoids on apoptosis and clearance of apoptotic cells

TheScientificWorldJournal

Volumn 7, Issue , 2007, Pages 1165-1181

  McColl, Aisleen ^a   Michlewska, Sylwia ^a   Dransfield, Ian ^a   Rossi, Adriano G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Glucocorticoids; Inflammation; Macrophage phagocytosis

Indexed keywords

COMPLEMENT COMPONENT C1Q; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HYDROCORTISONE; I KAPPA B ALPHA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 8; METHYLPREDNISOLONE; PROTEIN BCL 2; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL DIFFERENTIATION; ENZYME INHIBITION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MACROPHAGE; PHAGOCYTOSIS; REVIEW; TRANSACTIVATION; TREATMENT FAILURE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DRUG RESISTANCE; GLUCOCORTICOIDS; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; INFLAMMATION; MACROPHAGES; MONOCYTES; PHAGOCYTOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, GLUCOCORTICOID; TRANS-ACTIVATION (GENETICS);

EID: 34548249241     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.224     Document Type: Review

References (121)

1. Haslett, C., Savill, J.S., Whyte, M.K., Stern, M., Dransfield, I., and Meagher, L.C. (1994) Granulocyte apoptosis and the control of inflammation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 345, 327-333.
2. Cosio, B.G., Torrego, A., and Adcock, I.M. (2005) [Molecular mechanisms of glucocorticoids]. Arch. Bronconeumol. 41, 34-41.
3. Gardai, S.J., Hoontrakoon, R., Goddard, C.D., Day, B.J., Chang, L.Y., Henson, P.M., and Bratton, D.L. (2003) Oxidant-mediated mitochondrial injury in eosinophil apoptosis: enhancement by glucocorticoids and inhibition by granulocyte-macrophage colony-stimulating factor. J. Immunol. 170, 556-566.
4. Haslett, C. (1999) Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med. 160, S5-11.
5. Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
6. Savill, J.S., Wyllie, A.H., Henson, J.E., Walport, M.J., Henson, P.M., and Haslett, C. (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83, 865-875.
7. Stern, M., Meagher, L., Savill, J., and Haslett, C. (1992) Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148, 3543-3549.
8. Martin, M.C., Dransfield, I., Haslett, C., and Rossi, A.G. (2001) Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 276, 45041-45050.
9. Ward, C., Murray, J., Clugston, A., Dransfield, I., Haslett, C., and Rossi, A.G. (2005) Interleukin-10 inhibits lipopolysaccharide-induced survival and extracellular signal-regulated kinase activation in human neutrophils. Eur. J. Immunol. 35, 2728-2737.
10. Ward, C., Dransfield, I., Murray, J., Farrow, S.N., Haslett, C., and Rossi, A.G. (2002) Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J. Immunol. 168, 6232-6243.
11. Murray, J., Barbara, J.A., Dunkley, S.A., Lopez, A.F., Van Ostade, X., Condliffe, A.M., Dransfield, I., Haslett, C., and Chilvers, E.R. (1997) Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90, 2772-2783.
12. Wyllie, A.H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556.
13. Meagher, L.C., Cousin, J.M., Seckl, J.R., and Haslett, C. (1996) Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156, 4422-4428.
14. Cox, G. (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154, 4719-4725.
15. Serhan, C.N., Brain, S.D., Buckley, C.D., Gilroy, D.W., Haslett, C., O'Neill, L.A., Perretti, M., Rossi, A.G., and Wallace, J.L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332.
16. Rossi, A.G., Hallett, J.M., Sawatzky, D.A., Teixeira, M.M., and Haslett, C. (2007) Modulation of granulocyte apoptosis can influence the resolution of inflammation. Biochem. Soc. Trans. 35, 288-291.
17. Liu, Y., Cousin, J.M., Hughes, J., Van Damme, J., Seckl, J.R., Haslett, C., Dransfield, I., Savill, J., and Rossi, A.G. (1999) Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639-3646.
18. Giles, K.M., Ross, K., Rossi, A.G., Hotchin, N.A., Haslett, C., and Dransfield, I. (2001) Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J. Immunol. 167, 976-986.
19. Woolley, K.L., Gibson, P.G., Carty, K., Wilson, A.J., Twaddell, S.H., and Woolley, M.J. (1996) Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154, 237-243.
20. Goulding, N.J. (2004) The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Curr. Opin. Pharmacol. 4, 629-636.
21. Bamberger, C.M., Bamberger, A.M., de Castro, M., and Chrousos, G.P. (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95, 2435-2441.
22. Oakley, R.H., Jewell, C.M., Yudt, M.R., Bofetiado, D.M., and Cidlowski, J.A. (1999) The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 274, 27857-27866.
23. Pratt, W.B. and Toft, D.O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306-360.
24. Barnes, P.J. (2006) Corticosteroids: the drugs to beat. Eur. J. Pharmacol. 533, 2-14.
25. Chandler, V.L., Maler, B.A., and Yamamoto, K.R. (1983) DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell 33, 489-499.
26. Drouin, J., Sun, Y.L., Tremblay, S., Lavender, P., Schmidt, T.J., de Lean, A., and Nemer, M. (1992) Homodimer formation is rate-limiting for high affinity DNA binding by glucocorticoid receptor. Mol. Endocrinol. 6, 1299-1309.
27. Dahlman-Wright, K., Wright, A., Gustafsson, J.A., and Carlstedt-Duke, J. (1991) Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J. Biol. Chem. 266, 3107-3112.
28. Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schutz, G. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541.
29. Barnes, P.J. (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Lond.) 94, 557-572.
30. Abbinante-Nissen, J.M., Simpson, L.G., and Leikauf, G.D. (1995) Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 268, L601-606.
31. Faust, D., Akoglu, B., Zgouras, D., Scheuermann, E.H., Milovic, V., and Stein, J. (2002) Anti-inflammatory drugs modulate C1q secretion in human peritoneal macrophages in vitro. Biochem. Pharmacol. 64, 457-462.
32. Hannon, R., Croxtall, J.D., Getting, S.J., Roviezzo, F., Yona, S., Paul-Clark, M.J., Gavins, F.N., Perretti, M., Morris, J.F., Buckingham, J.C., and Flower, R.J. (2003) Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 17, 253-255.
33. Arur, S., Uche, U.E., Rezaul, K., Fong, M., Scranton, V., Cowan, A.E., Mohler, W., and Han, D.K. (2003) Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4, 587-598.
34. Roviezzo, F., Getting, S.J., Paul-Clark, M.J., Yona, S., Gavins, F.N., Perretti, M., Hannon, R., Croxtall, J.D., Buckingham, J.C., and Flower, R.J. (2002) The annexin-1 knockout mouse: what it tells us about the inflammatory response. J. Physiol. Pharmacol. 53, 541-553.
35. Maderna, P., Yona, S., Perretti, M., and Godson, C. (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J. Immunol. 174, 3727-3733.
36. Abraham, S.M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., and Clark, A.R. (2006) Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883-1889.
37. Sakai, D.D., Helms, S., Carlstedt-Duke, J., Gustafsson, J.A., Rottman, F.M., and Yamamoto, K.R. (1988) Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2, 1144-1154.
38. De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E., and Haegeman, G. (2000) Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. U. S. A. 97, 3919-3924.
39. Karin, M. and Chang, L. (2001) AP-1 - glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol. 169, 447-451.
40. Tak, P.P. and Firestein, G.S. (2001) NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11.
41. Rahman, I. and MacNee, W. (1998) Role of transcription factors in inflammatory lung diseases. Thorax 53, 601-612.
42. Reichardt, H.M., Tuckermann, J.P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., and Schutz, G. (2001) Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168-7173.
43. Tuckermann, J.P., Reichardt, H.M., Arribas, R., Richter, K.H., Schutz, G., and Angel, P. (1999) The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J. Cell Biol. 147, 1365-1370.
44. Karin, M. (1998) New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93, 487-490.
45. Urnov, F.D. and Wolffe, A.P. (2001) Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 20, 2991-3006.
46. Adcock, I.M., Ito, K., and Barnes, P.J. (2004) Glucocorticoids: effects on gene transcription. Proc. Am. Thorac. Soc. 1, 247-254.
47. De Bosscher, K., Vanden Berghe, W., and Haegeman, G. (2001) Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 15, 219-227.
48. Ito, K., Barnes, P.J., and Adcock, I.M. (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20, 6891-6903.
49. Norman, A.W., Mizwicki, M.T., and Norman, D.P. (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov. 3, 27-41.
50. Buttgereit, F. and Scheffold, A. (2002) Rapid glucocorticoid effects on immune cells. Steroids 67, 529-534.
51. Long, F., Wang, Y.X., Liu, L., Zhou, J., Cui, R.Y., and Jiang, C.L. (2005) Rapid nongenomic inhibitory effects of glucocorticoids on phagocytosis and superoxide anion production by macrophages. Steroids 70, 55-61.
52. Buckingham, J.C. (2006) Glucocorticoids: exemplars of multi-tasking. Br. J. Pharmacol. 147(Suppl 1), S258-268.
53. Chen, Y.Z. and Qiu, J. (1999) Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid. Mol. Cell Biol. Res. Commun. 2, 145-149.
54. Croxtall, J.D., Choudhury, Q., and Flower, R.J. (2000) Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br. J. Pharmacol. 130, 289-298.
55. Barnes, P.J. and Adcock, I.M. (2003) How do corticosteroids work in asthma? Ann. Intern. Med. 139, 359-370.
56. Webster, J.C., Oakley, R.H., Jewell, C.M., and Cidlowski, J.A. (2001) Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. U. S. A. 98, 6865-6870.
57. Kozaci, D.L., Chernajovsky, Y., and Chikanza, I.C. (2007) The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritis. Rheumatology (Oxford) 46, 579-585.
58. Ito, K., Lim, S., Caramori, G., Chung, K.F., Barnes, P.J., and Adcock, I.M. (2001) Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J. 15, 1110-1112.
59. Schacke, H., Docke, W.D., and Asadullah, K. (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 96, 23-43.
60. Catley, M. (2007) Dissociated steroids. TheScientificWorldJOURNAL 7, 421-430.
61. Whyte, M.K., Meagher, L.C., MacDermot, J., and Haslett, C. (1993) Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol. 150, 5124-5134.
62. Dransfield, I., Buckle, A.M., Savill, J.S., McDowall, A., Haslett, C., and Hogg, N. (1994) Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J. Immunol. 153, 1254-1263.
63. Dransfield, I., Stocks, S.C., and Haslett, C. (1995) Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood 85, 3264-3273.
64. Savill, J.S., Henson, P.M., and Haslett, C. (1989) Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge- sensitive" recognition mechanism. J. Clin. Invest. 84, 1518-1527.
65. Hart, S.P., Ross, J.A., Ross, K., Haslett, C., and Dransfield, I. (2000) Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 7, 493-503.
66. Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L., and Henson, P.M. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207-2216.
67. Gregory, C.D. and Devitt, A. (2004) The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113, 1-14.
68. Liu, G., Wu, C., Wu, Y., and Zhao, Y. (2006) Phagocytosis of apoptotic cells and immune regulation. Scand. J. Immunol. 64, 1-9.
69. Michlewska, S., McColl, A., Rossi, A.G., Megson, I.L., and Dransfield, I. (2007) Clearance of dying cells and autoimmunity. Autoimmunity 40, 267-273.
70. Savill, J., Hogg, N., Ren, Y., and Haslett, C. (1992) Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90, 1513-1522.
71. Platt, N., Suzuki, H., Kurihara, Y., Kodama, T., and Gordon, S. (1996) Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. U. S. A. 93, 12456-12460.
72. Brown, S., Heinisch, I., Ross, E., Shaw, K., Buckley, C.D., and Savill, J. (2002) Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 418, 200-203.
73. Fadok, V.A., Bratton, D.L., Rose, D.M., Pearson, A., Ezekewitz, R.A., and Henson, P.M. (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85-90.
74. Ogden, C.A., deCathelineau, A., Hoffmann, P.R., Bratton, D., Ghebrehiwet, B., Fadok, V.A., and Henson, P.M. (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194, 781-795.
75. Scott, R.S., McMahon, E.J., Pop, S.M., Reap, E.A., Caricchio, R., Cohen, P.L., Earp, H.S., and Matsushima, G.K. (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207-211.
76. Savill, J. (1997) Recognition and phagocytosis of cells undergoing apoptosis. Br. Med. Bull. 53, 491-508.
77. Meagher, L.C., Savill, J.S., Baker, A., Fuller, R.W., and Haslett, C. (1992) Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J. Leukoc. Biol. 52, 269-273.
78. Hughes, J., Liu, Y., Van Damme, J., and Savill, J. (1997) Human glomerular mesangial cell phagocytosis of apoptotic neutrophils: mediation by a novel CD36-independent vitronectin receptor/thrombospondin recognition mechanism that is uncoupled from chemokine secretion. J. Immunol. 158, 4389-4397.
79. Stern, M., Savill, J., and Haslett, C. (1996) Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am. J. Pathol. 149, 911-921.
80. Voll, R.E., Herrmann, M., Roth, E.A., Stach, C., Kalden, J.R., and Girkontaite, I. (1997) Immunosuppressive effects of apoptotic cells. Nature 390, 350-351.
81. Fadok, V.A., Bratton, D.L., Konowal, A., Freed, P.W., Westcott, J.Y., and Henson, P.M. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890-898.
82. Gaipl, U.S., Kuhn, A., Sheriff, A., Munoz, L.E., Franz, S., Voll, R.E., Kalden, J.R., and Herrmann, M. (2006) Clearance of apoptotic cells in human SLE. Curr. Dir. Autoimmun. 9, 173-187.
83. Tas, S.W., Quartier, P., Botto, M., and Fossati-Jimack, L. (2006) Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann. Rheum. Dis. 65, 216-221.
84. Taylor, P.R., Carugati, A., Fadok, V.A., Cook, H.T., Andrews, M., Carroll, M.C., Savill, J.S., Henson, P.M., Botto, M., and Walport, M.J. (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192, 359-366.
85. Botto, M., Dell'Agnola, C., Bygrave, A.E., Thompson, E.M., Cook, H.T., Petry, F., Loos, M., Pandolfi, P.P., and Walport, M.J. (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56-59.
86. Rossi, A.G., Sawatzky, D.A., Walker, A., Ward, C., Sheldrake, T.A., Riley, N.A., Caldicott, A., Martinez-Losa, M., Walker, T.R., Duffin, R., Gray, M., Crescenzi, E., Martin, M.C., Brady, H.J., Savill, J.S., Dransfield, I., and Haslett, C. (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12, 1056-1064.
87. Sawatzky, D.A., Willoughby, D.A., Colville-Nash, P.R., and Rossi, A.G. (2006) The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am. J. Pathol. 168, 33-41.
88. Madsen-Bouterse, S.A., Rosa, G.J., and Burton, J.L. (2006) Glucocorticoid modulation of Bcl-2 family members A1 and Bak during delayed spontaneous apoptosis of bovine blood neutrophils. Endocrinology 147, 3826-3834.
89. Colotta, F., Re, F., Polentarutti, N., Sozzani, S., and Mantovani, A. (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80, 2012-2020.
90. Lee, A., Whyte, M.K., and Haslett, C. (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54, 283-288.
91. Hannah, S., Mecklenburgh, K., Rahman, I., Bellingan, G.J., Greening, A., Haslett, C., and Chilvers, E.R. (1995) Hypoxia prolongs neutrophil survival in vitro. FEBS Lett. 372, 233-237.
92. Walsh, G.M. (1997) Mechanisms of human eosinophil survival and apoptosis. Clin. Exp. Allergy 27, 482-487.
93. Herold, M.J., McPherson, K.G., and Reichardt, H.M. (2006) Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 63, 60-72.
94. McConkey, D.J., Hartzell, P., Jondal, M., and Orrenius, S. (1989) Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem. 264, 13399-13402.
95. Whyte, M.K., Savill, J., Meagher, L.C., Lee, A., and Haslett, C. (1997) Coupling of neutrophil apoptosis to recognition by macrophages: coordinated acceleration by protein synthesis inhibitors. J. Leukoc. Biol. 62, 195-202.
96. Chilvers, E.R., Rossi, A.G., Murray, J., and Haslett, C. (1998) Regulation of granulocyte apoptosis and implications for anti-inflammatory therapy. Thorax 53, 533-534.
97. Liles, W.C., Dale, D.C., and Klebanoff, S.J. (1995) Glucocorticoids inhibit apoptosis of human neutrophils. Blood 86, 3181-3188.
98. Nittoh, T., Fujimori, H., Kozumi, Y., Ishihara, K., Mue, S., and Ohuchi, K. (1998) Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. Eur. J. Pharmacol. 354, 73-81.
99. Ward, C., Chilvers, E.R., Lawson, M.F., Pryde, J.G., Fujihara, S., Farrow, S.N., Haslett, C., and Rossi, A.G. (1999) NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 274, 4309-4318.
100. Ashwell, J.D., Lu, F.W., and Vacchio, M.S. (2000) Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18, 309-345.
101. Schmidt, M., Pauels, H.G., Lugering, N., Lugering, A., Domschke, W., and Kucharzik, T. (1999) Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta. J. Immunol. 163, 3484-3490.
102. Ehrchen, J., Steinmuller, L., Barczyk, K., Tenbrock, K., Nacken, W., Eisenacher, M., Nordhues, U., Sorg, C., Sunderkotter, C., and Roth, J. (2007) Glucocorticoids induce differentiation of a specifically activated, antiinflammatory subtype of human monocytes. Blood 109, 1265-1274.
103. Helmberg, A., Auphan, N., Caelles, C., and Karin, M. (1995) Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14, 452-460.
104. Novac, N., Baus, D., Dostert, A., and Heinzel, T. (2006) Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter. FASEB J. 20, 1074-1081.
105. Ramdas, J. and Harmon, J.M. (1998) Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells. Endocrinology 139, 3813-3821.
106. Cox, G. and Austin, R.C. (1997) Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis. J. Leukoc. Biol. 61, 224-230.
107. Letuve, S., Druilhe, A., Grandsaigne, M., Aubier, M., and Pretolani, M. (2002) Critical role of mitochondria, but not caspases, during glucocorticosteroid-induced human eosinophil apoptosis. Am. J. Respir. Cell Mol. Biol. 26, 565-571.
108. Ruiz, L.M., Bedoya, G., Salazar, J., Garcia de, O.D., and Patino, P.J. (2002) Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species. Inflammation 26, 215-222.
109. Distelhorst, C.W. (2002) Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 9, 6-19.
110. Petit, P.X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., and Gougeon, M.L. (1995) Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130, 157-167.
111. Veis, D.J., Sorenson, C.M., Shutter, J.R., and Korsmeyer, S.J. (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240.
112. McColl, K.S., He, H., Zhong, H., Whitacre, C.M., Berger, N.A., and Distelhorst, C.W. (1998) Apoptosis induction by the glucocorticoid hormone dexamethasone and the calcium-ATPase inhibitor thapsigargin involves Bc1-2 regulated caspase activation. Mol. Cell. Endocrinol. 139, 229-238.
113. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809.
114. Rossi, A.G., McCutcheon, J.C., Roy, N., Chilvers, E.R., Haslett, C., and Dransfield, I. (1998) Regulation of macrophage phagocytosis of apoptotic cells by cAMP. J. Immunol. 160, 3562-3568.
115. Hart, S.P., Dougherty, G.J., Haslett, C., and Dransfield, I. (1997) CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J. Immunol. 159, 919-925.
116. McCutcheon, J.C., Hart, S.P., Canning, M., Ross, K., Humphries, M.J., and Dransfield, I. (1998) Regulation of macrophage phagocytosis of apoptotic neutrophils by adhesion to fibronectin. J. Leukoc. Biol. 64, 600-607.
117. Newman, S.L., Henson, J.E., and Henson, P.M. (1982) Phagocytosis of senescent neutrophils by human monocytederived macrophages and rabbit inflammatory macrophages. J. Exp. Med. 156, 430-442.
118. Heasman, S.J., Giles, K.M., Rossi, A.G., Allen, J.E., Haslett, C., and Dransfield, I. (2004) Interferon gamma suppresses glucocorticoid augmentation of macrophage clearance of apoptotic cells. Eur. J. Immunol. 34, 1752-1761.
119. Scannell, M., Flanagan, M.B., deStefani, A., Wynne, K.J., Cagney, G., Godson, C., and Maderna, P. (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J. Immunol. 178, 4595-4605.
120. Armbrust, T., Nordmann, B., Kreissig, M., and Ramadori, G. (1997) C1Q synthesis by tissue mononuclear phagocytes from normal and from damaged rat liver: up-regulation by dexamethasone, down-regulation by interferon gamma, and lipopolysaccharide. Hepatology 26, 98-106.
121. Korb, L.C. and Ahearn, J.M. (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525-4528.